Detalles de la búsqueda
1.
Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.
Sex Transm Dis;
46(10): 663-669, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464859
2.
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.
Int J Cancer;
139(12): 2812-2826, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27541373
3.
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
Lancet Oncol;
16(7): 775-86, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26071347
4.
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.
J Infect Dis;
210(4): 517-34, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24610876
5.
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
BMC Infect Dis;
14: 551, 2014 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25927224
6.
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
J Infect Dis;
208(9): 1391-6, 2013 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24092907
7.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol;
13(1): 100-10, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075170
8.
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol;
13(1): 89-99, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075171
9.
Screen-and-treat approach in managing cervical cancer precursor lesions: An observational study with 524 women.
Eur J Obstet Gynecol Reprod Biol;
280: 78-82, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36434824
10.
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
Gynecol Oncol;
127(3): 440-50, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22940493
11.
Safety of Conservative Management of High-Grade Squamous Intraepithelial Lesion in Women Under 30 Years Old.
Womens Health Rep (New Rochelle);
3(1): 601-607, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35814605
12.
Mortality in pregnancy and the postpartum period in women with severe acute respiratory distress syndrome related to COVID-19 in Brazil, 2020.
Int J Gynaecol Obstet;
155(3): 475-482, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185314
13.
Conservative treatment of microinvasive squamous cell carcinoma of the cervix stage IA1: Defining conization height to an optimal oncological outcome.
PLoS One;
16(7): e0253998, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283862
14.
Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems.
Int J Gynaecol Obstet;
152(1): 7-11, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33128771
15.
Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome.
Eur J Obstet Gynecol Reprod Biol X;
3: 100020, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31403112
16.
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
BMJ Open;
6(8): e011371, 2016 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566633
17.
MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
Cancer Epidemiol Biomarkers Prev;
24(10): 1539-47, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26261088
18.
Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Clin Vaccine Immunol;
22(4): 361-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25651922
19.
Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.
Clin Vaccine Immunol;
22(2): 235-44, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25540273
20.
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
Hum Vaccin Immunother;
10(8): 2147-62, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424918